Maine Prescription Monitoring Program (PMP) Enhanced Project

Maine Prescription Monitoring Program (PMP) Enhancement Project

The objective of this project is to establish and update an OBH/PDMP Database to be the analytic infrastructure, integrating PMP data and building on PMP data, to improve understanding of interrelated factors or determinants that contribute to the risk of prescription misuse, addiction and overdose.  We are looking at leveraging the power of the PMP to couple prescription data with other data to analyze the relationships of the myriad of interventions, including prescription patterns, to enhance our prevention and treatment process in the State of Maine.  While the goal is reducing overdoses and deaths, it becomes clear that we must look at the larger “system” to find solutions.  The State of Maine is already integrated with RxCheck and as such will include drugs provided in other states to our citizens.

This project represents the next clinical step.  By integrating existing patient level data, the work will be twofold: integrating the data and building the normalized data into a useable graph database.  We will establish the OBH database using PMP data and data from other existing sources of patient level data.by June 2022 and update it subsequently.  This OBH/PDMP database will be the analytic platform for analyses on relationships between programs and interventions.

The work envisioned here is like setting up an in house HIE.  As a result, the vendors who will bid on this work will have HIE experience, a world-class Master Patient Index (MPI) and hosting capabilities.  In addition, we will be looking for vendors with solid experience and references on integration work, preferably in the Master Data Governance arena.  We may find that one vendor can meet each requirement although we intend to issue two RFPs.

The database will allow the State of Maine to refine policy and legal approaches to prevent overdoses and deaths from opioid-like substances.  The plan is that all citizens who are exposed to prescriptions will be tracked on a patient-level basis through all interventions in the various programs and provision of services they receive.  This covers all patients in Maine. The overall deliverables of this database are: Patient-level analysis platform and a public facing aggregate platform.